相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A sensitive UPLC-ESI-MS/MS method for the quantification of cinnamic acid in vivo and in vitro: application to pharmacokinetic and protein binding study in human plasma
Seung-Hyun Jeong et al.
JOURNAL OF PHARMACEUTICAL INVESTIGATION (2020)
First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer
Anna Capasso et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Preliminary report of a phase 1b/2a trial, an oral inhibitor of phosphorylated P68 (P-p68) which mediates β-catenin nuclear translocation in advanced triple-negative breast cancer (TNBC).
Jennifer Robinson Diamond et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A Validated HPLC-MS/MS Method for the Quantification of Supinoxin in Rat Plasma and Its Application to Pharmacokinetic Study
Jong-Woo Jeong et al.
ACTA CHROMATOGRAPHICA (2017)
The anticancer effects of supinoxin (RX-5902) in pancreatic carcinoma.
Young Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The anticancer effects of supinoxin (RX-5902) in renal cell cancer.
Young Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Results of a phase I study of RX-5902: An orally bioavailable inhibitor of phosphorylated P68, targeting solid tumors.
S. Gail Eckhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
A Novel Anti-Cancer Agent, 1-(3,5-Dimethoxyphenyl)-4-[(6-Fluoro-2-Methoxyquinoxalin-3-yl)Aminocarbonyl] Piperazine (RX-5902), Interferes With -Catenin Function Through Y593 Phospho-p68 RNA Helicase
Gina Chun Kost et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
P68 RNA helicase as a molecular target for cancer therapy
Ting-Yu Dai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
RNA helicases p68 and p72: multifunctional proteins with important implications for cancer development
Frances V. Fuller-Pace et al.
FUTURE ONCOLOGY (2011)
Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives
Young Bok Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression
Liuqing Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from β-catenin
Liuqing Yang et al.
CELL (2006)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation
LQ Yang et al.
MOLECULAR CANCER RESEARCH (2005)
Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours
M Causevic et al.
ONCOGENE (2001)
分享论文
